What is involved in long-term monitoring of benign prostatic hyperplasia (BPH)?

Updated: Feb 19, 2021
  • Author: Levi A Deters, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print
Answer

Patients with BPH who have symptoms significant enough to be placed on medication should be evaluated during office visits to discuss the efficacy of the medication and potential dose adjustment. These visits should take place at least biannually. Patients should undergo prostate cancer screening at least annually.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!